Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly
Mixed pattern some users describe deeper sleep, others describe early-morning waking
So, while we dont get much B12 in the water anymore, we dont get much cholera, either, which is a good thing
Most peptide regimens used in obesity and metabolic research show good overall tolerability, but they still carry risks, particularly for patients with diabetes, cardiovascular disease, or cancer history
doi:10.1155/2013/424163 [17] Wojciechowska A, Osowski A, Jwik M, Grecki R, Rynkiewicz A, Wojtkiewicz J